“In science, we go by evidence”

On GM crops: a conversation with Pushpa M Bhargava, eminent biotechnologist, Padma Shree awardee and founder of the Centre for Cellular and Molecular Biology, Hyderabad

prasanna

Prasanna Mohanty | January 31, 2013


Pushpa M Bhargava
Pushpa M Bhargava

Dr Bhargava, what do you think of environmentalist Mark Lynas’ sudden change of heart – from being an anti-GM crusader to a pro-GM crusader? [Read more here]

I think it doesn’t change the situation one bit. We have no credentials of him and one swallow doesn’t make a summer.

In science, we go by evidence. Nothing has been added to the evidence that we have for or against the GM crop. Opinion is completely irrelevant in science if it is not based on evidence, existing or new. In science, if we ever change our opinion we always give reasons. Here, none is given.

To the community of scientists, he (Lynas) is a completely unknown entity and no different from somebody one might pick up on the street randomly.

How do we know that he is not purchased? How do we know the person exists and not merely a story created by the multinational seed companies making GMOs? The very fact that this story has been released without scientific evidence makes the case against GM crops stronger.

What is your stand on promoting GM crops in India?

Firstly, we must make a socio-economic assessment whether there is a problem at all. We had a problem in case of cotton but not for brinjal at all.

Secondly, we must see if alternatives are available to the GM technology. In case of cotton, there was a problem but there were alternatives – integrated pest management, bio-pesticides and organic agriculture. So we didn’t need it.

Third, if it turns out that we need GM crop we must go through a very strict safety assessment. This has not been done for any GM crop (in India). Nearly 30 tests need to be conducted. Out of these, about six tests have been done and that to, done badly. So for all practical purposes, no safety assessment has been done.

Therefore, a moratorium on GM crop is justified.

Also read interviews with Kavitha Kuruganti and Suman Sahai

Comments

 

Other News

CSIR’s new Innovation Complex to foster translational research, industry collaboration

India is home to many small and big industries where research is carried out, yet many innovators are not able to find a platform to bring their ideas into fruition. Despite having a vast network of government laboratories that perform ground breaking research, these innovations struggle to translate into

Deepa Malik and the incredible story of her indomitable spirit

Bring It On: The Incredible Story of My Life By Deepa Malik HarperCollins, 312 pages, Rs 499

RINL gets Rs 11,440 crore revival plan

The Cabinet Committee on Economic Affairs (CCEA), chaired by PM Narendra Modi, has approved the revival plan for RINL for a total of Rs 11,440 crore. The infusion includes ₹10,300 crore as equity capital into Rashtriya Ispat Nigam Ltd. (RINL) and Conversion of ₹1,140 crore working capital loan as 7% No

How SpaDeX Mission revolutionises space exploration

In a historic achievement, the Space Docking Experiment (SpaDeX) mission’s docking operation was successfully completed on Thursday, marking India’s entry into the elite group of nations capable of executing space docking operations. With this success, India becomes the fourth country in the wo

New insights into the Ramayana’s deep cultural resonance

Many Ramayanas, Many Lessons By Anand Neelakantan HarperCollins, 456 pages, Rs 599 The Ramayana, one of the most

Maha Kumbh Mela: A primer on key rituals and practices

The Maha Kumbh Mela, celebrated as the world`s largest spiritual gathering, is a breathtaking convergence of faith, culture, and ancient tradition. Rooted in Hindu mythology, this sacred festival unfolds four times over a course of twelve years, rotating between four revered cities in India: Haridwar, Ujja

Visionary Talk: Amitabh Gupta, Pune Police Commissioner with Kailashnath Adhikari, MD, Governance Now



Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter